Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Neoplasms | 15 | 2018 | 313 | 2.770 |
Why?
|
| Musculoskeletal Diseases | 4 | 2019 | 36 | 1.740 |
Why?
|
| Soft Tissue Neoplasms | 8 | 2020 | 124 | 1.620 |
Why?
|
| Magnetic Resonance Imaging | 22 | 2023 | 3476 | 1.590 |
Why?
|
| Glomus Tumor | 2 | 2022 | 10 | 1.380 |
Why?
|
| Diagnostic Imaging | 4 | 2018 | 452 | 1.370 |
Why?
|
| Tarsal Bones | 2 | 2023 | 11 | 1.210 |
Why?
|
| Neurofibroma | 2 | 2022 | 12 | 0.820 |
Why?
|
| Fibula | 3 | 2018 | 31 | 0.810 |
Why?
|
| Neurilemmoma | 2 | 2022 | 37 | 0.800 |
Why?
|
| Radiography | 12 | 2020 | 790 | 0.780 |
Why?
|
| Femur | 4 | 2015 | 107 | 0.750 |
Why?
|
| Diagnosis, Differential | 13 | 2020 | 1546 | 0.720 |
Why?
|
| Tibia | 3 | 2015 | 80 | 0.710 |
Why?
|
| Sarcoma | 4 | 2015 | 222 | 0.700 |
Why?
|
| Sarcoma, Synovial | 2 | 2020 | 20 | 0.670 |
Why?
|
| Joint Diseases | 3 | 2014 | 47 | 0.670 |
Why?
|
| Lipoma | 2 | 2020 | 25 | 0.660 |
Why?
|
| Fibroma | 2 | 2020 | 30 | 0.660 |
Why?
|
| Giant Cell Tumor of Tendon Sheath | 1 | 2020 | 3 | 0.630 |
Why?
|
| Knee Prosthesis | 1 | 2019 | 24 | 0.590 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 121 | 0.550 |
Why?
|
| Image Enhancement | 2 | 2013 | 505 | 0.530 |
Why?
|
| Audiovisual Aids | 1 | 2017 | 7 | 0.520 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 111 | 0.520 |
Why?
|
| Knee Joint | 4 | 2014 | 161 | 0.480 |
Why?
|
| Femoral Neoplasms | 2 | 2014 | 19 | 0.480 |
Why?
|
| Teaching | 1 | 2017 | 141 | 0.470 |
Why?
|
| Giant Cell Tumor of Bone | 3 | 2004 | 15 | 0.470 |
Why?
|
| Infarction | 1 | 2015 | 25 | 0.460 |
Why?
|
| Finger Phalanges | 1 | 2015 | 3 | 0.460 |
Why?
|
| Metacarpal Bones | 1 | 2015 | 12 | 0.450 |
Why?
|
| Musculoskeletal System | 1 | 2015 | 16 | 0.450 |
Why?
|
| Osteoma | 1 | 2014 | 4 | 0.440 |
Why?
|
| Radiology | 1 | 2017 | 192 | 0.430 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 109 | 0.430 |
Why?
|
| Patella | 1 | 2014 | 30 | 0.420 |
Why?
|
| Patellofemoral Joint | 1 | 2014 | 19 | 0.410 |
Why?
|
| Knee Injuries | 1 | 2014 | 53 | 0.410 |
Why?
|
| Hand Injuries | 1 | 2013 | 16 | 0.390 |
Why?
|
| Software | 1 | 2017 | 670 | 0.380 |
Why?
|
| Humans | 39 | 2023 | 93515 | 0.380 |
Why?
|
| Artifacts | 2 | 2019 | 243 | 0.370 |
Why?
|
| Neurofibromatosis 1 | 1 | 2012 | 42 | 0.360 |
Why?
|
| Bone Marrow Diseases | 1 | 2011 | 37 | 0.350 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 282 | 0.350 |
Why?
|
| Soft Tissue Infections | 1 | 2011 | 27 | 0.350 |
Why?
|
| Athletic Injuries | 1 | 2013 | 103 | 0.350 |
Why?
|
| Bone Diseases | 2 | 2011 | 52 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2018 | 2585 | 0.300 |
Why?
|
| Postoperative Complications | 1 | 2019 | 2562 | 0.270 |
Why?
|
| Forearm | 1 | 2007 | 32 | 0.260 |
Why?
|
| Adult | 15 | 2023 | 27918 | 0.260 |
Why?
|
| Osteonecrosis | 3 | 2015 | 20 | 0.250 |
Why?
|
| Leg | 1 | 2007 | 140 | 0.250 |
Why?
|
| Connective Tissue Diseases | 1 | 2007 | 75 | 0.240 |
Why?
|
| Male | 17 | 2023 | 44557 | 0.240 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 157 | 0.240 |
Why?
|
| Female | 19 | 2023 | 48702 | 0.220 |
Why?
|
| Adolescent | 10 | 2013 | 9606 | 0.220 |
Why?
|
| Bone Diseases, Developmental | 1 | 2004 | 11 | 0.220 |
Why?
|
| Sacrum | 1 | 2004 | 83 | 0.210 |
Why?
|
| Referral and Consultation | 1 | 2007 | 375 | 0.210 |
Why?
|
| Synovial Cyst | 2 | 2020 | 17 | 0.200 |
Why?
|
| Cysts | 1 | 2004 | 99 | 0.200 |
Why?
|
| Edema | 1 | 2023 | 70 | 0.200 |
Why?
|
| Spinal Neoplasms | 1 | 2004 | 127 | 0.200 |
Why?
|
| Shoulder Joint | 1 | 2004 | 98 | 0.190 |
Why?
|
| Neurofibromatoses | 1 | 2022 | 13 | 0.190 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2022 | 20 | 0.190 |
Why?
|
| Fingers | 1 | 2022 | 53 | 0.190 |
Why?
|
| Neoplasms, Second Primary | 1 | 2004 | 245 | 0.180 |
Why?
|
| Lower Extremity | 1 | 2022 | 99 | 0.180 |
Why?
|
| Scapula | 1 | 2000 | 25 | 0.160 |
Why?
|
| Epidermal Cyst | 1 | 2020 | 7 | 0.160 |
Why?
|
| Ganglion Cysts | 1 | 2020 | 5 | 0.160 |
Why?
|
| Middle Aged | 10 | 2015 | 27573 | 0.160 |
Why?
|
| Fasciitis | 1 | 2020 | 13 | 0.160 |
Why?
|
| Pain | 1 | 2022 | 414 | 0.150 |
Why?
|
| Arteriovenous Malformations | 1 | 2020 | 49 | 0.150 |
Why?
|
| Hand | 1 | 2020 | 143 | 0.150 |
Why?
|
| Periostitis | 1 | 2018 | 3 | 0.140 |
Why?
|
| Voriconazole | 1 | 2018 | 19 | 0.140 |
Why?
|
| Muscular Diseases | 2 | 2011 | 67 | 0.140 |
Why?
|
| Prosthesis Failure | 1 | 2019 | 123 | 0.140 |
Why?
|
| Prosthesis Design | 1 | 2019 | 297 | 0.140 |
Why?
|
| Antifungal Agents | 1 | 2018 | 122 | 0.140 |
Why?
|
| Retrospective Studies | 5 | 2023 | 10164 | 0.130 |
Why?
|
| Child | 7 | 2012 | 7355 | 0.130 |
Why?
|
| Osteomyelitis | 2 | 2011 | 56 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2715 | 0.130 |
Why?
|
| Ultrasonography | 1 | 2020 | 702 | 0.130 |
Why?
|
| Computer Graphics | 1 | 2017 | 100 | 0.130 |
Why?
|
| Reoperation | 1 | 2019 | 702 | 0.120 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 189 | 0.110 |
Why?
|
| Patient Positioning | 1 | 2013 | 65 | 0.100 |
Why?
|
| Neoplasm Staging | 3 | 2011 | 2017 | 0.090 |
Why?
|
| Argon Plasma Coagulation | 1 | 2011 | 6 | 0.090 |
Why?
|
| Curettage | 1 | 2011 | 14 | 0.090 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2011 | 7 | 0.090 |
Why?
|
| Soft Tissue Injuries | 1 | 2011 | 16 | 0.090 |
Why?
|
| Hyperparathyroidism | 1 | 2011 | 65 | 0.090 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2011 | 25 | 0.090 |
Why?
|
| Fractures, Stress | 1 | 2011 | 15 | 0.090 |
Why?
|
| Sarcoidosis | 1 | 2011 | 92 | 0.080 |
Why?
|
| Osteoporosis | 1 | 2011 | 129 | 0.080 |
Why?
|
| Catheter Ablation | 2 | 2011 | 345 | 0.070 |
Why?
|
| Eosinophilic Granuloma | 1 | 2008 | 10 | 0.070 |
Why?
|
| Ileum | 1 | 2008 | 167 | 0.070 |
Why?
|
| Pain Clinics | 1 | 2007 | 2 | 0.070 |
Why?
|
| Oncology Service, Hospital | 1 | 2007 | 6 | 0.070 |
Why?
|
| Osteosarcoma | 2 | 2004 | 158 | 0.060 |
Why?
|
| Orthopedics | 1 | 2007 | 134 | 0.060 |
Why?
|
| Endometriosis | 1 | 2005 | 63 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 7061 | 0.050 |
Why?
|
| Hemangioma, Cavernous | 1 | 2004 | 66 | 0.050 |
Why?
|
| Aged | 3 | 2015 | 20434 | 0.050 |
Why?
|
| Radius | 1 | 2003 | 30 | 0.050 |
Why?
|
| Histiocytosis, Sinus | 1 | 2003 | 17 | 0.050 |
Why?
|
| Young Adult | 2 | 2012 | 6930 | 0.050 |
Why?
|
| Peripheral Nerves | 1 | 2022 | 36 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 3830 | 0.050 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 2002 | 3 | 0.050 |
Why?
|
| Chondroblastoma | 1 | 2002 | 5 | 0.050 |
Why?
|
| Osteoma, Osteoid | 1 | 2002 | 7 | 0.050 |
Why?
|
| Osteochondroma | 1 | 2002 | 7 | 0.050 |
Why?
|
| Biopsy | 3 | 2011 | 1175 | 0.040 |
Why?
|
| Bursitis | 1 | 2002 | 14 | 0.040 |
Why?
|
| Hematoma | 1 | 2002 | 106 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2001 | 378 | 0.030 |
Why?
|
| Thigh | 2 | 2005 | 41 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 1261 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 4560 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 1713 | 0.020 |
Why?
|
| Infant | 1 | 2000 | 3220 | 0.020 |
Why?
|
| Arm Bones | 1 | 2011 | 2 | 0.020 |
Why?
|
| Leg Bones | 1 | 2011 | 7 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 302 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 876 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 2011 | 217 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 1190 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 1723 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2011 | 9099 | 0.020 |
Why?
|
| Prognosis | 2 | 2004 | 3911 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1917 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 3054 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2005 | 148 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2004 | 36 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 2441 | 0.010 |
Why?
|
| Hemangioendothelioma | 1 | 2003 | 9 | 0.010 |
Why?
|
| Ameloblastoma | 1 | 2003 | 9 | 0.010 |
Why?
|
| Neurofibrosarcoma | 1 | 2003 | 5 | 0.010 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 2003 | 23 | 0.010 |
Why?
|
| Sarcoma, Ewing | 1 | 2003 | 42 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 2003 | 54 | 0.010 |
Why?
|
| Chordoma | 1 | 2003 | 42 | 0.010 |
Why?
|
| Sample Size | 1 | 2003 | 128 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 5410 | 0.010 |
Why?
|
| Calcinosis | 1 | 2004 | 222 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 884 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 889 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 1948 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2003 | 1524 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2003 | 1061 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2004 | 3829 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 1922 | 0.010 |
Why?
|
| Risk Factors | 1 | 2003 | 5899 | 0.010 |
Why?
|